Actively Recruiting
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Led by Children's Hospital Los Angeles · Updated on 2024-04-18
10
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
CONDITIONS
Official Title
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 7 and 21 years
- Diagnosis of mild to moderate ulcerative colitis
You will not qualify if you...
- Use of ulcerative colitis therapy within 4 weeks before starting study medication
- Infectious colitis
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
Actively Recruiting
Research Team
S
Sonia Michail, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here